The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, randomized study of JMT101 in combination with irinotecan and SG001 versus regorafenib in patients with metastatic colorectal adenocarcinoma (mCRC).
 
Jianmin Xu
No Relationships to Disclose
 
Wentao Tang
No Relationships to Disclose
 
Xiugao Yang
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
Yang Yang
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
Qiwen Chen
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
Jianhong Cheng
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
Xuechao Wan
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
Yane Song
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group
 
Mengke Li
Employment - CSPC Zhongqi Pharmaceutical Technology Co. Ltd., CSPS Pharmaceutical Group